<DOC>
	<DOC>NCT00646009</DOC>
	<brief_summary>The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma</brief_summary>
	<brief_title>Symbicort Onset of Action 2</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>At least 18 years of age Diagnosis of asthma and baseline lung function test results as determined by the protocol Required and received inhaled corticosteroids within timeframe and doses specified in the protocol Severe asthma or asthma that is markedly effected by seasonal factors Has required and received noninhaled corticosteroids within the previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with betablockers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>adults</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/formoterol</keyword>
	<keyword>Advair Diskus</keyword>
	<keyword>Ventolin</keyword>
</DOC>